This long-term cardiac CT follow-up study of 52 patients who underwent left atrial appendage occlusion with the Amplatzer Amulet device found stable left atrial appendage sealing, low rates of device-related thrombosis, and excellent long-term device durability over a median 5.8-year follow-up period.
From perspectives on left atrial appendage occlusions or original research on the effects of ageing or diabetes and vulnerable plaque to chimney/snorkel stenting during TAV-in-TAV – there’s something for everyone in this issue of EuroIntervention...take a look.
With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)